A Post-Marketing Safety Study using a Pregnancy Registry to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy (C3671041)

First published 07/06/2024

Last updated 03/06/2025

EU PAS number:

EUPAS1000000179

Study

Ongoing

Documents

Study protocol

Initial protocol

C3671041_RSV VACCINE PROTOCOL AMENDMENT 1 V2.0_15MAY2024.pdf

English (309.99 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs